HIV CareLink Newsletter

CareLink is a newsletter distributed by e-mail to physicians and other HIV care providers. It provides Clinical Practice Updates that contain the most current treatment information available pertaining to HIV/AIDS and related conditions. The newsletter also includes information on training opportunities in the region, summaries of recent HIV research articles, the latest treatment guidelines, and other useful information. Special bulletins with urgent clinical information are issued as necessary.

If you would like to receive CareLink, click here.

CareLink Issues | 2006 | 2007 | 2008 |

Volume 8 2007  
December 27 #17
  • Highlights From The 4th International AIDS Society Conference On HIV Pathogenesis, Treatment And Prevention. July 22-25, 2007- Part II
December 5 #16
  • Special Bulletin: Adult and Adolescent Antiretroviral Guidelines Updated December 1, 2007
November 20 #15
  • Special Bulletin: Perinatal Antiretroviral Guidelines Updated – November 2, 2007
November 1 #14
  • Early Initiation of ARV Therapy in Perinatally Infected Infants Decreases Mortality
October 16 #13
  • Special Bulletin: First Agent in Integrase Inhibitor Class, Raltegravir (ral-TEG-ra-vir) (Isentress TM; eye-SEN-tris), Approved for Use in HIV-1 Infected Treatment Experienced Adults
September 25 #12
  • Hightlights from the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention July 22-25, 2007
September 12 #11
  • New Safety Information for Pregnant Women and Pediatric Patients Concerning Viracept® (Nelfinavir)
August 23 #10
  • FDA Approves First CCR5 Inhibitor Miraviroc (Selzentry™)
July 24 #9
  • Oral Health and HIV
June 14 #8
  • Working with Patients Who Use Stimulants
May 29 #7
  • Special Bulletin: Update on the 14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, CA
    Part 3
May 18 #6
  • Special Bulletin: Update on the14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, CA
    Part 2
May 4 #5
  • Special Bulletin: Entecavir (Baraclude®) in Hepatitis B Virus (HBV) / HIV Co-Infected Patients
April 20 #4
  • Hepatitis C and HIV Co-Infection
  • Florida Department of Health (DOH) Issues Notice of Change in Treatment of Gonorrhea
March 21 #3
  • Update on the14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, CA
February 16 #2
  • Practical Guide to the Management of Gynecological Problems in HIV/AIDS Infected Women
  • Changes Made to Sustiva ® and Fuzeon ® Product Labeling
  • Microbicide Trial Stopped
January 18 #1
  • Adherence Considerations for HIV Infection: Focus on Minority Populations

CareLink Issues | 2006 | 2007 | 2008 |